MWNA
SGTX

Marshall Wace North America’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Marshall Wace North America’s Portfolio SGTX Stock Details SGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,001
Closed -$1.25M – 1832
2020
Q4 		$1.25M Buy
+2,001
New +$1.25M 0.01% 882